# Linda T. Vahdat

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/linda-t-vahdat/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,167 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 66 |
| i10-index | 156 |
| Last Known Institution | Dartmouth College |
| OpenAlex ID | https://openalex.org/A5056927697 |
| ORCID iD | https://orcid.org/0000-0002-3522-7382 |
| Works | 485 |

## Researcher papers

- [Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer](https://scholariq.org/papers/sacituzumab-govitecan-hziy-in-refractory-metastatic-triple-negative-breast/)
- [Randomized Trial of Black Cohosh for the Treatment of Hot Flashes Among Women With a History of Breast Cancer](https://scholariq.org/papers/randomized-trial-of-black-cohosh-for-the-treatment-of-hot-flashes-among-women/)
- [Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer](https://scholariq.org/papers/biomarker-analyses-in-the-phase-iii-ascent-study-of-sacituzumab-govitecan-versus/)
- [Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy](https://scholariq.org/papers/augmented-her-2-specific-immunity-during-treatment-with-trastuzumab-and/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)

## Researcher university

- [Dartmouth College](https://scholariq.org/institutions/dartmouth-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.